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Use of ribonucleic acid (RNA) interference to regulate protein expression has become an
important research topic and gene therapy tool, and therefore, finding suitable vehicles for
delivery of small RNAs into cells is of crucial importance. Layered double metal hydroxides such
as hydrotalcite (HT) have shown great promise as nonviral vectors for transport of deoxyribose
nucleic acid (DNA), proteins, and drugs into cells, but the adsorption of RNAs to these materials
has been little explored. In this study, the binding of small RNAs with different lengths and
levels of secondary structure to HT nanoparticles has been analyzed and compared to results
obtained with small DNAs in concurrent experiments. Initial experiments established the
spectrophotometric properties of HT in aqueous solutions and determined that HT particles could
be readily sedimented with near 100% efficiencies. Use of RNAþHT cosedimentation
experiments as well as electrophoretic mobility shift assays demonstrated strong adsorption of
RNA 25mers to HT, with twofold greater binding of single-stranded RNAs relative to doublestranded molecules. Strong affinities were also observed with ssRNA and dsRNA 54mers and
with more complex transfer RNA molecules. Competition binding and RNA displacement
experiments indicated that RNA-HT associations were strong and were only modestly affected by
C 2015 American Vacuum Society.
the presence of high concentrations of inorganic anions. V
[http://dx.doi.org/10.1116/1.4936393]

I. INTRODUCTION
Medicinal nanotechnology aims to advance the field of
drug/biomolecule delivery by improving cell targeting and
biocompatibility while minimizing the toxicity of the carrier.
Particularly for targeted therapies, nanoparticle carriers offer
the ability to bind, protect, and deliver molecules to the
desired tissues. Nanoparticles can achieve controlled release
of the drugs/biomolecules through changes in the physiological environment by triggers such as changes in pH levels,
temperature, or via enzymatic activity.1,2 Nanoparticles vary
in size and in chemical composition, and because of the large
number of nanomaterials that exist, it is of great interest to
find and optimize nanoparticles that are suitable for therapeutic purposes. Optimal carriers would not only be able to
deliver and release the drug/biomolecule into targeted cells,
but should also be biodegradable and have an appropriate
lifespan to maximize their therapeutic activity. The eventual
fate of the nanoparticles is of great importance as accumulation of foreign particles can be detrimental to cells.
Moreover, nanoparticles intended for biomedical
a)
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applications must be nontoxic and must not elicit an immune
response.
Nanoparticles differ from bulk materials in that they are
defined as being 100 nm in at least one dimension.1–5 This
feature is precisely what makes them so attractive for use in
a wide range of applications. Such a minute size causes
nanoparticles to have high surface-area-to-mass ratios,
thereby increasing their chemical reactivity. They also have
an increased ability to interact with biological polymers due
to their similarity in size to biological components. An efficient uptake of molecules through the cell membrane
requires their size to be at or below 200 nm, thus penetration
by nanoparticles is enabled by their size.1 Additionally,
nanoparticles have been shown to partake in lysosomal
escape after endocytosis.1 It is then without surprise that
nanoparticles have become interesting candidates as delivery
tools for drugs or biomolecules.
Nanoclays are inorganic layered silicates, usually aluminosilicates. They can either be natural clay minerals found
abundantly in nature or clays that can be easily synthesized
in the lab. As such, they are inexpensive and have been
shown to be useful in a multitude of applications.6–10 Two
commonly studied nanoclays, hydrotalcite (HT) and
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montmorillonite (MMT), have high anion (100–500 mEq/
100 g) or cation (80–150 mEq/100 g) exchange capacities,
respectively.8–11 This allows them to adsorb large amounts
of biomolecules. MMT is classified as a cationic nanoclay
due to its high exchange capacity of cations, while HT is an
anionic clay capable of exchanging anions. Recently, both
nanoclays have shown great promise for the delivery of biomolecules and drugs into mammalian cells.4,6–10,12
HT is a member of the layered double hydroxide family
and has been found to be particularly promising for gene
delivery and controlled drug/deoxyribose nucleic acid (DNA)
release systems.7,13–17 Similar to MMT, HT is commonly
used in a variety of different applications, such as water treatment, flame-retardants, sorbents, cosmetics, and as enteric
delivery vehicles for antacids.5,8,16 HT can be described with
the formula [MII1-xMIIIx(OH)2(Am)x/mnH2O] (x ¼ 0.2–0.4;
n ¼ 0.5–1), where MII can be divalent metal cations such as
Mg, Ni, and Co, MIII represents trivalent metal cations such
as Al and Fe, and Am are exchangeable anions such as
CO32, SO42, and Cl. HT is structurally similar to a
brucite layer, Mg(OH)2, as each Mg2þ ion is octahedrally
surrounded by six OH ions and every octahedral subunit
pair shares edges, leading the two-dimensional layer to
expand infinitely.13–16 Isomorphic substitution of Mg2þ ions
by Al3þ ions gives these layers a net positive charge.
This charge is balanced by the anions that are accommodated in the interlayer gallery via electrostatic bonding.13–16
These anions are frequently also accompanied by water
molecules.
HT is a strong candidate for a biodelivery system by
nearly every metric: low cost, good biocompatibility, chemical versatility, anionic exchange capacity, low toxicity to
mammalian cells, easy synthesis, high drug loading density
and transportation, cellular uptake, and the ability to provide
protection for biomolecules and drugs. Extensive studies
have shown that HT can form intercalated structures with
different types of anions, such as inorganic anions, complex
anions, anionic polymers, drugs, and organic biochemical
anions such as amino acids and nucleic acids.13,16,18–20
These interactions occur by an anion exchange mechanism
in which the anions residing in the interlayer space are
replaced by the aforementioned anions.21 This intercalation
allows for the protection of drugs/biomolecules from
degradation.
In addition to the reports described above, Kim et al.
recently demonstrated that the intercalation of both methotrexate and 5-fluorouracil (5-FU) into the HT framework
increases the effectiveness of tumor growth suppression.22
The Barahuie et al. group successfully delivered two anticancer drugs, chlorogenic acid and protocatehuic acid, using
modified hydrotalcite.23 The adsorption capability of HT to
single- and double-stranded DNA was evidenced by a previous study performed in this lab, which noted that adsorption
was dependent on the conditions of synthesis of the HT as
well as on the charge density of both the DNA molecules
and the HT.9 Li et al. successfully transfected DNA plasmids
encoding the enhanced green fluorescent protein into NSC
Biointerphases, Vol. 10, No. 4, December 2015
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34 (mouse motor neuron cells).24 Delivery of ribonucleic
acid (RNA) molecules into cells after intercalation into HT
has not been studied as intensively as delivery of DNA, but a
few studies exist.12,15,25,26 Interestingly, Li et al. demonstrated that the combination of short interfering RNA
(siRNA) and anticancer drugs such as 5-FU loaded onto HT
enhances the delivery efficiency into cancerous cells, demonstrating a potential advantage of combining drugs with
biomolecules for cancer therapy using nanoclays.26
RNA interference (RNAi) is a silencing mechanism that
occurs in eukaryotic cells as a protein synthesis regulation
event.27–30 This process is intricately linked to the silencing
that derives from microRNAs (miRNAs). miRNAs are
encoded in the nucleus of cells as long double-stranded hairpin RNA molecules that are subsequently cleaved by an
enzyme (Drosha) into pre-miRNA. The pre-miRNA molecule is then exported out of the nucleus to the cytoplasm by
association with the enzyme exportin 5. Pre-miRNA is processed once again by another enzyme, Dicer, creating a
miRNA duplex. The miRNA associates with a complex of
proteins that contain catalytic activity, termed the RISC
complex. The final processing events occur during the
miRNA’s association with RISC, where the antisense strand
of the miRNA is separated from the sense strand and remains
bound to the RISC complex. The antisense strand then acts
as a guide to target a complementary sequence in an mRNA,
blocking translation of the mRNA into a specific protein.
In vitro and in vivo studies have shown that RNAi therapy
can be used to target single-gene diseases as well as diseases
that are caused by the overexpression of specific proteins.27–30 Similar to traditional gene therapy applications,
RNAi-based therapy would benefit immensely from optimized and biocompatible nanoparticles that can efficiently
deliver small synthetic noncoding RNAs into cells. Although
it is important for the nanoclays to deliver genes efficiently
to the nucleus for gene therapy, RNAi strategies have more
leeway as it is sufficient simply to deliver siRNA into the
cytoplasm where it can be incorporated into the RNAi pathway. Strides have been made in the pursuit of finding optimal nanoparticles for RNAi, but common viral and nonviral
vectors have shown drawbacks, which is where the study of
nanoclays as delivery vectors for RNAi-based therapies
could be beneficial.
While the adsorption capability and binding mode of
DNA molecules to HT have been studied using adsorption
assays and structural techniques such as x-ray diffraction
and SEM analysis, work on the binding of HT to RNA is
limited. It is important to analyze the adsorption and binding
affinities of different RNA molecules to HT as RNA interference therapy gains traction. In contrast to DNAs, even small
RNA molecules can form secondary and tertiary structures
that are likely to have strong effects on their affinities for the
nanomaterial. A direct comparison of the adsorption of small
DNA molecules versus small RNAs with and without secondary structure could reveal important factors in determining adequate nanoparticle delivery vehicles for emerging
RNA-based therapies. The aim of this project was to analyze
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the adsorption of small RNA molecules containing different
lengths and structures to HT nanoparticles. It is hoped that
this work will help accelerate the development and optimization of RNA delivery systems for RNAi-based therapy.
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trendline equation relating HT concentration to absorbance
produced earlier. All assays were performed using four or
five replicates, and the results were averaged.
2. Double-stranded DNA/RNA preparation

II. MATERIALS AND METHODS
A. Materials

Hydrotalcite ([Mg2þ.82Al3þ.18(OH)2]Cl.18) with a
charge density of 300 mEq/100 g was prepared through precipitation followed by hydrothermal heating in a Parr reactor
at 150  C.9 The following DNA and RNA oligonucleotides
were purchased from Integrated DNA Technologies: the
single-stranded (ss)DNA 25mer Pvu4a (AAATGAGTCAC
CCAGATCTAAATAA), its complement cPvu4a (TTATT
TAGATCTGGGTGACTCATTT), the single-stranded RNA
(ssRNA) 25mer PvuRNA (AAATGAGTCACCCAGATC
TAAATAA), its complement cPvuRNA (TTATTTAGA
TCTGGGTGACTCATTT), the double-stranded (ds)RNA
54mer RNALoop (AAAUGAGUCACCCAGAUCUAAAU
AAGUAAUUAUUUUAGAUCUGGGUGACUCAUU), and
the ssRNA 54mer RNAStr8 (AAAUGAGUCACCCAGAU
CUAAAUAAGUAAAAAUGAGUCACCCAGAUCUAAA
UAA). Transfer RNA (tRNA) purified from Escherichia coli
cells (Sigma-Aldrich #R8759), Tris base, sodium carbonate,
and sodium sulfate were purchased from Sigma-Aldrich.
Low MW DNA Ladder and double-stranded RNA (dsRNA)
Ladder were purchased from New England Biolabs. Agarose
was obtained from Gold Biotechnology. Boric acid was purchased from JT Baker. SYBR Gold was purchased from
Invitrogen Life Sciences. Eppendorf Flex-Tubes (1.5 ml)
that exhibit minimal leaching of polypropylene additives
were purchased from Eppendorf.31 All electrophoresis
experiments were performed using 11  14 cm Horizon gel
rigs (Labrepco) and an Amersham/GE Healthcare EPS 601
power supply.
B. Methods
1. UV-Vis spectroscopy

Spectroscopic absorbance measurements and scans of HT
were performed using a Cary 100 Bio UV-Vis spectrophotometer or a BioRad SmartSpec 3000 spectrophotometer.
For scans, a 50 lg/ml HT sample in double-deionized water
(ddH2O) was scanned using a wavelength range of
200–800 nm. A time-dependent spectroscopy scan was also
performed on the 50 lg/ml HT sample from 200 to 300 nm.
The time points measured were 0, 1, 5, 10, 20, and 30 min.
Five HT samples (50, 25, 12.5, 6.25, and 3.125 lg/ml) were
also scanned from 200 to 300 nm and their absorbances at
260 nm plotted into a best-fit trendline using Microsoft Excel
in order to generate a standard line and equation. HT suspensions in ddH2O (2, 1, 0.5, and 0.25 mg/ml) were centrifuged
at 21 000  g for 5 min, the top half of the supernatants were
removed from each tube, and their absorbances at 260 nm
were measured. The concentration of HT remaining in the
supernatants after centrifugation was calculated using the
Biointerphases, Vol. 10, No. 4, December 2015

To make double-stranded DNA, aliquots of 525 ng/ll
Pvu4a and 525 ng/ll cPvu4a were combined, Tris (pH 7.4)
was added (5 mM final), and solutions were mixed in a total
volume of 1 ml to achieve a final dsDNA concentration of
1050 ng/ll. For double-stranded RNA, aliquots of 600 ng/ll
PvuRNA, 600 ng/ll cPvuRNA, ddH2O, and Tris (5 mM
final) were mixed as before in a total volume of 1 ml for a
final dsRNA concentration of 1200 ng/ll. The solutions were
placed in a heating block for 5 min at 100  C and then
allowed to anneal while cooling to RT for 30 min.
Confirmation of successful dsRNA and dsDNA formation
was determined using gel electrophoresis with 3.5% agarose
and 0.5 Trisþboric acid (TB) electrophoresis buffer. Gels
were run for approximately 10 min at 350 V as described by
Sanderson et al.32 Gels were stained in 0.5 lg/ml ethidium
bromide for 15 min. A “Low MW DNA ladder” (New
England Biolabs) was run with the dsDNA samples while a
“dsRNA ladder” was used for the analysis of dsRNA
samples.
3. Preparation of DNA and RNA/hydrotalcite solutions
for adsorption assays

HT-ssDNA solutions were typically prepared by combining 75 ll of HT (0.25, 0.5, 1, 2, or 4 mg/ml), 3 ll 750 ng/ll
Pvu4a DNA and ddH2O in a final volume of 150 ll. For
dsDNA binding studies, 52.5 ll 50 ng/ll dsDNA (Pvu4a
annealed to cPvu4a) was added to the dsDNA/HT solutions.
HT-ssRNA solutions were prepared by mixing 75 ll of
HT (0.25, 0.5, 1, 2, or 4 mg/ml), 10 ll 300 ng/ll PvuRNA
and ddH2O in a final volume of 150 ll. For dsRNA, 30 ll
200 ng/ll dsRNA (PvuRNA annealed to cPvuRNA) was
added. HT-54mer RNA binding mixtures were prepared by
mixing 19 ll 300 ng/ll RNAStr8 or RNALoop with HT and
ddH2O in a final volume of 150 ll. For tRNA-HT assays,
10 ll E. coli tRNA (300 ng/ll) was added to HT in the same
final volumes as above. Assay mixtures were shaken in a
microcentrifuge tube shaker for 5 min and then centrifuged
at 21 000  g for 5 min at RT.
4. DNA/HT and RNA/HT adsorption analysis

Immediately after centrifugation, the top 60 ll of the supernatant of each sample was transferred to a new microcentrifuge tube. The absorbance of the unbound DNA or RNA
was then measured at 260 nm. The average of four or five
samples for each DNA-HT and RNA-HT series was calculated. The percentage of total nucleic acids bound to the HT
was calculated by subtracting the absorbance of free nucleic
acids in the supernatant from the original nucleic acid-only
absorbance. The difference was then divided by the original
nucleic acid-only absorbance.
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5. Analysis of RNA/hydrotalcite binding using mobility
shift assays

For ssRNA-HT electrophoretic mobility shift assays
(EMSAs), 300 ng ssRNA was mixed with ddH2O and HT (0,
0.02, 0.04, 0.08, 0.16, 0.32, or 0.64 mg/ml) in a final volume
of 20 ll. dsRNA EMSAs contained 200 ng nucleic acid and
HT concentrations of 0, 0.16, 0.32, 0.64, 1.28, 2.56, and
5.12 mg/ml in a final volume of 20 ll. RNALoop EMSAs
contained 100 ng nucleic acid, while RNAStr8 assays contained 150 ng and both were mixed with HT concentrations
of 0, 0.04, 0.08, 0.16, 0.32, and 0.64 mg/ml. tRNA EMSAs
consisted of 150 ng tRNA and HT concentrations of 0, 0.16,
0.32, 0.64, 1.28, and 2.56 mg/ml. After mixing and letting
the solutions incubate for 5 min at RT, 4 ll of 30% glycerol
was added to give a final volume of 24 ll and 18 ll of each
sample was loaded onto the gel.
The EMSA gels were designed to effectively separate
small oligonucleotides using agarose gels with the parameters described by Sanderson et al.32 ssRNA (25mer), dsRNA
(25mer), RNALoop (54mer), and RNAStr8 (54mer) EMSAs
were performed using 3.5% agarose gels while tRNA was
run on a 1.2% gel. Agarose gels were made in 45–50 ml
0.5 TB buffer and 11  14 cm gels. All samples were run
at 350 V, except tRNA, which was run at 400 V. Gels were
run for only 4–10 min to minimize bound RNA off-times
and to reduce band diffusion. SYBR Gold (10 000) was
diluted to 4 in 40 ml water and was layered on top of the
gels to completely cover them for 15 min at RT. Each gel
was then destained in water with shaking for 20 min and
imaged using the ProteinSimple RED gel documentation
system. Band densitometry analysis for each gel was performed using IMAGEJ software (http://imagej.nih.gov/ij/) and
multiple image exposures to avoid saturation. Dissociation
constants (KD) were calculated by transferring the data generated from IMAGEJ to Microsoft Excel and creating a best fit
trendline equation. KD values were determined from three
separate gels, and the results were averaged.
6. Salt competition assays and displacement

For the competition assays, 50 ll 2 mg/ml HT was mixed
with 5 ll 300 ng/ll ssRNA plus 0, 1, 10, 100, or 500 mM
concentrations of either sodium carbonate or sodium sulfate
in a total volume of 100 ll. The displacement assays were
prepared using the same amounts of RNA, ddH2O, HT, and
salt; however, for these experiments, the RNA, water, and
HT were combined and mixed together first and the salts
were added last. The samples were agitated in an automated
vortex mixer for 5 min and then centrifuged for 5 min at
21 000  g. The A260 of each sample was measured as
described above.
III. RESULTS
The overarching goal of this study was to analyze the
association of RNA molecules of varying lengths and structures with the nanoclay HT. Specifically, we were interested
in assessing the binding affinity of HT for different forms of
Biointerphases, Vol. 10, No. 4, December 2015
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RNA: ssRNA 25mers, dsRNA 25mers, dsRNA 54mers with
a short 4 nt connecting loop (RNALoop), ssRNA 54mers
(RNAStr8), and tRNAs (more complex dsRNAs with multiple stem-loop regions).
In a previous study, we tested the affinities of small and
large DNA molecules for HT nanoparticles that had been
prepared in different ways.9 Highest binding was observed
with HT that had been synthesized at elevated temperatures
(80 or 150  C) and prepared with an anion exchange capacity
of 300 mEq/100 g. Therefore, all binding experiments performed in the current study used HT synthesized at 150  C
with an exchange capacity of 300 mEq/100 g. The first
approach used to quantitate binding was to incubate the
nucleic acids and HT together and then measure the A260 of
DNA or RNA remaining in the supernatant after centrifugation. Before performing the binding assays, it was necessary
to investigate the optical and sedimentation properties of the
HT to ensure that the spectroscopic analysis was accurate
and not affected by potential absorbance contributions from
the HT nanoparticles.
To characterize the absorbance of HT, a 50 lg/ml sample
was subjected to an absorbance scan from 200 to 800 nm.
The scan revealed HT absorbance over most of this range,
with stronger absorbance at the lower wavelengths [Fig.
1(a)]. Because the HT nanoparticles may be capable of scattering light, some of the apparent absorbance may also be
due to this phenomenon. Centrifugation binding assays typically involve the use of multiple samples whose absorbance
is measured shortly after centrifugation. As a result, even
though the measurements can be made quickly, not all samples are tested at the same time. HT particles naturally sediment toward the bottoms of tubes (and cuvettes) when
suspended in aqueous solutions, which may increase the variability of measurements. We assessed whether taking absorbance scans at different times after addition to a cuvette
would produce lower readings over time due to continuous
sedimentation of the nanoclay. As seen in Fig. 1(b), the absorbance of a 50 lg/ml HT solution decreased only slightly
between 0 and 30 min after addition to a cuvette. This result
indicates that natural sedimentation does not appreciably
affect the absorbance of HT solutions if measurements are
taken relatively quickly, e.g., within 5 min or less.
HT samples were prepared in ddH2O at different concentrations and their absorbances were scanned from 200 to
300 nm, revealing that the absorbance of HT is concentration
dependent [Fig. 1(c)]. From this data, the A260 at each concentration was plotted against the HT concentration and a
linear relationship was observed [Fig. 1(d)]. This wavelength
was chosen because DNAs and RNAs have an absorbance
peak at 260 nm that is used routinely for their quantitation.
The linear relationship allowed generation of a trendline
equation (y ¼ 0.002x þ 0.0183) relating absorbance at
260 nm (y) to HT concentration (x). This relationship was
then used in a set of experiments to find out how easily HT
particles can be sedimented using a standard biochemistry
laboratory microcentrifuge. The experiments used HT stock
solutions of 0.25, 0.5, 1, and 2 mg/ml, which were spun for
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FIG. 1. Evaluation of the optical and sedimentation properties of 300–150 HT (prepared at 150  C with exchange capacity of 300 mEq/100 g). (a) Absorbance
scan of 50 lg/ml HT in ddH2O; (b) Scan of a 50 lg/ml HT solution after incubation at RT in a cuvette for different times after an initial mixing step; (c) HT
absorbance is concentration dependent; (d) Absorbance at 260 nm is linearly related to concentration; (e) Determination of the efficiency of sedimentation of
HT particles after centrifugation for 5 min at 21 000  g.

5 min at 21 000  g at RT. After each spin, the A260 of the
supernatant was measured and converted to an HT concentration using the equation derived in Fig. 1(d). The data are
tabulated in Fig. 1(e) and show that at the highest HT concentration, 2 mg/ml, a 5 min spin at 21 000  g is sufficient
for 99.8% of HT to be removed from the supernatant. At
0.25 and 0.5 mg/ml HT, 100% of the HT was removed.
These results indicate that a 5-min spin is sufficient to sediment essentially all of the HT, and therefore, the nanoclay
would not contribute substantially to absorbance measurements of nucleic acids.
The sequences and structures of the nucleic acids used in
this study are shown in Figs. 2(a) and 2(b). Although the
main focus of the study was to assess the binding of RNAs
to HT, we included single- and double-stranded DNAs in
order to have a direct comparison to a nucleic acid that has
been established to have high affinity for nanoclays. The
sequences of the bases in the DNA and RNA 25mers used in
Biointerphases, Vol. 10, No. 4, December 2015

the study were identical except for the natural occurrence of
uracil in the RNAs and thymine in the DNAs. We used short
ssRNAs, dsRNAs, and RNAs with stem-loops that mimic either siRNAs or miRNAs, which are RNA molecules
involved in regulation of protein synthesis by RNA interference.27–30 In addition, we also included tRNAs, which fold
into more complex L-shaped secondary and tertiary
structures.33
In order to investigate the adsorption of nucleic acids to
HT we employed centrifugation binding assays.8 By mixing
the nucleic acids with HT in water and spinning the samples
for 5 min at 21 000  g, we were able to quantitate the
amount of the free nucleic acids versus those that adsorbed
to the sedimented HT by measuring the A260 of the supernatant after the spin. In the first set of experiments, DNA and
RNA 25mers were mixed with increasing amounts of HT.
The percentage of DNA or RNA that became bound is plotted against HT concentration in Fig. 3(a). Averages and
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FIG. 2. Sequences (a) and structural representations (b) of the different types
of single- and double-stranded nucleic acids used in this study.
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standard deviations from four or five assays at each concentration of HT are shown. Binding of ssDNA and ssRNA
25mers to HT was similar and substantially stronger than the
binding of the double-stranded oligonucleotides over most
of the range of HT concentrations used. Indeed, the percentage of bound single-stranded nucleic acids at HT concentrations from 0.2 to 1.0 mg/ml was twofold higher than that of
the double-stranded molecules [Figs. 3(a) and 3(b)].
To confirm the data from the sedimentation studies in
Fig. 3(a) and to determine a dissociation constant for the
binding of HT to RNA, the affinity of the RNA 25mers for
HT was investigated through EMSAs. EMSAs are frequently
used to monitor the binding of proteins to DNA or RNA,
with the nucleic acid concentration held constant while reactions are performed with increasing amounts of protein.34
For the EMSAs with HT, 3.5% agarose gels were used in
order to resolve the small RNA oligonucleotides. The gels
were run at high voltages (350–400 V) with short run times
(4–10 min) to minimize diffusion and to reduce opportunities for dissociation during the run. As shown in the far left
lane of each gel in Fig. 3(c), free RNA migrated to the bottom of the gel and exhibited a bright band. The bright band
gradually disappeared as the concentration of HT in each
reaction mixture was increased. The disappearance of the
free RNA band and the appearance of HT-RNA smears
above the free RNA band are primarily due to the increased
sizes of the HT-RNA complexes, which reduces their

FIG. 3. Assessment of binding of ss and ds 25mers to HT using sedimentation assays and mobility shift assays; (a) The percentage of bound ss nucleic acids is
greater than that of bound ds nucleic acids over a broad range of HT concentrations; (b) Specific percentages of bound nucleic acids at 1 mg/ml HT;
(c) Representative EMSA gels run to assess adsorption of ssRNA and dsRNA 25mers; (d) KD values (averages 6 SD) calculated from three independent gels.
Biointerphases, Vol. 10, No. 4, December 2015
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mobilities. As RNA became bound to the HT, which is a
mixture of molecules of different sizes that have a sheetlike
structure, the resulting complexes were not able to sieve efficiently through the agarose pores. When the HT concentration reached 0.16 mg/ml, more than half of the ssRNA band
disappeared, indicating its association with HT. For dsRNA,
the band intensity reduction to less than half of the original
intensity became apparent after addition of 0.32 mg/ml HT.
Densitometry analysis was performed on the bands of each
EMSA gel using IMAGEJ software, the data were plotted to
generate a best-fit trendline equation, and a dissociation constant (KD) was calculated. The KD is defined in this type of
experiment as the concentration of HT at which the free
RNA is reduced to 50% of initial levels, indicating that 50%
of the RNA was bound to HT particles. Three or four EMSA
gels were run, apparent KD values were calculated, and the
results were averaged.
HT centrifugation studies indicated a twofold higher
binding affinity of ssRNA 25mers for HT compared to
dsRNAs over a wide range of HT concentrations [Figs. 3(a)
and 3(b)]. This twofold difference was further supported by
the EMSAs, which produced a KD of 0.16 mg/ml for HTssRNA and 0.39 mg/ml for HT-dsRNA complexes, roughly
a twofold difference [Fig. 3(d)]. A lower KD indicates a
stronger affinity between two moieties; therefore, ssRNA
displayed approximately twice the affinity for HT as dsRNA
under the conditions used in the experiments.
The results from the ssRNA and dsRNA 25mer assays
suggested that ssRNA had a greater affinity for HT than
dsRNA over a broad range of HT concentrations. This difference could be due to the lower net negative charge on the
ssRNA (25) compared to the dsRNA (50). Alternatively,
it may be that the helical structure of the dsRNA was a factor, potentially reducing its ability to be incorporated into
interlayer spaces. With these models in mind, we designed
new centrifugation and EMSA assays using two RNA molecules that have the same overall negative charge but different structures. The 54mer called RNAStr8 is single-stranded
and has no regions of complementary bases within itself,
which prevent the formation of secondary structures [Figs.
2(a) and 2(b)]. The 54mer RNALoop was designed to spontaneously fold upon itself to form 25 bp of double-stranded
RNA with a small 4 nt loop at one end, similar to a miRNA
[Fig. 2(b)]. To verify the structure of RNALoop, a sample of
this RNA was analyzed on a 3% agarose gel and its migration was compared to single-stranded RNAStr8. The analysis
revealed that most of the RNALoop oligonucleotide was
double-stranded after simply resuspending it in ddH2O
(Fig. 4, lane 2). After a heating and cooling step to promote
annealing of complementary strands (see Sec. II B), essentially all of the RNALoop had become double-stranded
(Fig. 4, lane 3).
In the initial centrifugation assays with the longer oligonucleotides, binding of the ssRNA 54mer RNAStr8 was
compared to that of the ssRNA 25mer PvuRNA used in Fig.
3. The percentage of free RNA remaining in the supernatant
after centrifugation is plotted against HT concentration in
Biointerphases, Vol. 10, No. 4, December 2015
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FIG. 4. Use of gel electrophoresis to confirm the double-stranded nature of
RNALoop 54mers. M, low molecular weight dsDNA ladder; lane 1,
RNAStr8 (ssRNA 54mer); lane 2, RNALoop (54mer capable of forming
25 bp of duplex RNA with a four nucleotide loop on one end) is mostly
double-stranded after simple resuspension in ddH2O; lane 3, RNALoop
becomes essentially completely double-stranded in 5 mM Tris (pH 7.4) after
heating at 90  C for 4 min and cooling for 30 min at RT. The gel contained
3% agarose dissolved in 0.5 TB (Tris-borate) buffer.

Fig. 5(a). Binding of the two ssRNAs was strong and similar
to each other, with greater than 85% of each RNA bound at
1 and 2 mg/ml HT. Direct comparison of binding of the ss
and ds 54mers (RNAStr8 and RNALoop) revealed that, in
contrast to the ss and ds 25mers, their affinities were similar
to each other [Fig. 5(b)]. For example, at 1 mg/ml HT,
70.7% of the RNALoop and 85.2% of the RNAStr8 RNA
was bound [Figs. 5(b) and 5(d)].
EMSA mobility shift assays indicated KD values of 0.13
6 0.02 for RNALoop and 0.19 6 0.05 for RNAStr8 [Figs.
5(c) and 5(e)]. The difference in these averages was not significant because they exhibited overlapping standard deviation ranges. In summary, the centrifugation experiments
indicated an 18.6% difference (70.7% vs 85.2% bound at
1 mg/ml HT) and the EMSAs pointed to a 38.8% difference
(0.13 vs 0.19 KD values) in binding affinities of the singleand double-stranded 54mers. The combined results suggest
that the affinities of the single- and double-stranded 54mers
for HT do not differ strongly from one another.
In addition to assessing the interactions of HT with
ssRNAs and dsRNAs, we also investigated the binding affinity of HT for more complex, 75–80 nt cloverleaf-like tRNA
molecules [Fig. 2(b)].33 tRNAs participate in the translation
of nucleic acids into proteins by recognizing the codons
encoded in mRNA. We performed centrifugation studies
using a mixture of pure E. coli bacterial tRNAs and the same
parameters that were used for the 25mers and 54mers. Using
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FIG. 5. HT binding studies with RNALoop and RNAStr8 54mers using centrifugation and mobility shift assays. (a) Percentage of unbound ssRNAs RNAStr8
(54mer) and PvuRNA (25mer) remaining in the supernatant after sedimentation in the presence of increasing amounts of HT; (b) Comparison of adsorption of
ss 54mer RNAStr8 and ds 54mer RNALoop; (c) Representative EMSA gels performed with RNALoop (upper gel) and RNAStr8 (lower gel); (d) Specific percentage of RNALoop and RNAStr8 bound at 1 mg/ml HT using centrifugation assays; (e) KD values (averages 6 SD) calculated from three or four independent gels.

centrifugation assays, approximately 90% of the tRNA molecules became bound to HT at 1 and 2 mg/ml HT [Fig. 6(a)],
which is similar to results observed with the ssRNA 25mers
and 54mers. Mobility shift assays produced an average KD of

0.21 6 0.01 for binding of tRNAs to HT, similar to the values
of 0.13 and 0.19 determined for the 54mers. A representative
EMSA gel is shown in Fig. 6(b). These data show that despite
having a larger and more complex three-dimensional structure

FIG. 6. Evaluation of adsorption of tRNAs containing complex folded structures to HT using (a) centrifugation binding assays and (b) EMSAs. Results from
three EMSA gels were averaged to calculate a KD of 0.210 6 0.006.
Biointerphases, Vol. 10, No. 4, December 2015
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than the RNAs tested previously, tRNAs exhibit similarly
high affinities for HT.
One of the attractive features of HT as a gene delivery
carrier is its ability to exchange anions from the interlayer
spacing. The HT that was used in the present study contained
negatively charged chlorine ions in the interlayer space,
which were readily exchanged for the negatively charged
nucleic acids. A past study showed that when HT containing
CO32 as the exchangeable anion is exposed to air, the anion
can be exchanged with carbonate derived from atmospheric
CO2.35 The authors of this study suggested that CO2 most
likely adsorbs to the Mg-OH sites mediated by reversible
acid-base interactions.35 The carbonate ion, being planar and
divalent, binds strongly in the gallery and will displace most
other anions.
Concern about anions displacing or competing off the
RNA from binding to HT led us to conduct a series of centrifugation binding assays with two distinct anions, carbonate (from Na2CO3) and sulfate (Na2SO4). Competition
assays were performed that involved simultaneously mixing
1 mg/ml HT with ssRNA 25mer PvuRNA (containing 5 lM
RNA, corresponding to 125 lM phosphate) and increasing
concentrations of sodium carbonate or sodium sulfate (1, 10,
100, or 500 mM). The percentage of free RNA in the presence and absence of the other anions is plotted against the
concentration of salt added in Fig. 7(a). At the highest concentrations of added salts, 500 mM, the amount of RNA
bound to HT was only reduced from 90%–95% to
50%–60% using either salt.
Displacement studies were performed in a similar manner
except that the anions were added last to the ssRNA-HT
mixture, after RNA-HT complexes had already formed.
Similar to the competition assays, at 500 mM anionic salt
concentration, approximately 50% of the RNA molecules
that had bound initially were displaced from the HT [Fig.
7(b)]. There were, however, differences at 10 and 100 mM,
with carbonate having the greatest impact at these concentrations. These experiments show that anions such as carbonate
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and sulfate can indeed compete with and be exchanged for
RNA, but the process is inefficient, even at very high concentrations of the anions.
IV. DISCUSSION
The main goal of this study was to analyze the binding of
RNA molecules with different structures to hydrotalcite.
Experiments demonstrated that a simple ion-exchange assay
involving centrifugation is a reliable method to measure
binding of the RNAs. Although HT absorbs light at 260 nm
in aqueous solutions, the nanoparticles were found to sediment exceptionally well after centrifugation in a standard
microcentrifuge, and therefore, they did not interfere with
A260 measurements of unbound RNA and DNA. It would not
be expected that hydrotalcite would absorb UV light
strongly, based on its structure. A possible contributor to the
apparent absorbance is the trace amounts of carbonate ion
that are adsorbed from the atmosphere.35 There may also be
some contribution from light scattering.
Centrifugation assays demonstrated that binding of
ssRNA 25mers to HT was similar to that of ssDNAs of the
same size. Binding of dsRNA and dsDNA 25mers was also
similar. However, the single-stranded 25mers exhibited a
twofold higher affinity for HT than the double-stranded
25mers over a broad range of HT concentrations.
Electrophoretic mobility shift assays confirmed this twofold
difference.
Past work by Ishihara et al. demonstrated that HT containing CO32 as the exchangeable anion can exchange it
with carbonate derived from atmospheric CO2 upon exposure to air.35 We tested the abilities of carbonate ions and
sulfate ions to compete with ssRNA 25mers for binding to
HT. In addition, we assessed whether bound RNAs could be
easily displaced by addition of increasing concentrations of
the two inorganic anions. The results revealed that the
ssRNA molecules were bound tightly to the HT and, while
they could be displaced, this process was inefficient and

FIG. 7. Common inorganic anions compete poorly with RNA for binding to HT. Centrifugation assays were performed with ssRNA 25mers, 1 mg/ml HT, and
either sodium carbonate (Na2CO3) or sodium sulfate (Na2SO4) at 0, 1, 10, 100, or 500 mM concentrations. (a) Carbonate or sulfate was added at the same time
as the RNA to assess their ability to compete with ssRNA for binding to HT. (b) Assessment of the abilities of carbonate and sulfate anions to displace RNA
molecules already bound to HT.
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required high concentrations of the displacing anions. It is
likely that the differences in binding affinities can be attributed in large part to the increased charge density and higher
number of potential contacts that can be formed by the
RNAs, which have 25 nucleotides, each of which contains
phosphates and other functional groups that can interact with
surface atoms on the HT. This phenomenon is likely to represent a cooperative effect. There are several points of interaction between the RNA and the HT; it is therefore difficult
for an anion that only bonds at one site to displace the RNA
completely.
Binding of the larger 54mers, RNAStr8 (ssRNA) and
RNALoop (dsRNA), was also evaluated. Centrifugation
assays indicated that the affinity of the ss 54mer RNAStr8
for HT was nearly identical to that of the ss 25mer PvuRNA.
Furthermore, no significant difference in adsorption could be
detected between ss RNAStr8 and ds RNALoop. EMSA mobility shift assays suggested that binding of RNALoop was
modestly stronger than that of RNAStr8. Thus, singlestranded 25mers bound HT more strongly than doublestranded 25mers, but this structural effect on binding was
not apparent when the longer 54mers were analyzed.
Centrifugation and mobility shift assays indicated that
tRNAs have high affinity for HT, despite having larger and
more complex structures, as well as the largest overall
charge densities of the molecules tested here. At present, it is
unclear if the 75 nt long tRNAs are binding in the same
manner as the 25 and 54 nt long oligonucleotides. The possibility that some RNA species can intercalate into HT interlayer spaces while other RNAs can only bind to the surfaces
or edges remains unexplored.
V. CONCLUSIONS
In this study, we have demonstrated that small RNAs
bind strongly to layered double hydroxide nanoparticles,
exhibiting affinities similar to those of DNA molecules.
Very small single-stranded RNAs (25 nt) were found to bind
to hydrotalcite with twice the affinity of double-stranded
RNAs of the same length, but this ss:ds difference was not
observed in longer RNA oligonucleotides. The unique ability
of RNA to form simple and complex secondary structures
not typically seen in DNA was also assessed; results indicated that these secondary structures did not interfere with
the strong binding of the RNAs to HT. Assessing the affinities and modes of binding of small RNAs to HT is an important fundamental step in optimizing the use of this material
and other nonviral vectors as carriers for RNAi therapy
applications.
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